The George Institute

This study tested whether a low-dose blood thinner called rivaroxaban could lower the risk of major heart problems (like heart attack or stroke) in people with advanced chronic kidney disease or kidney failure on dialysis. About 1,753 participants were randomly assigned to receiv…

This study tested whether a tablet app used by community health workers could improve the detection and management of anemia, gestational diabetes, and high blood pressure in over 3,400 pregnant women in rural India. Women in the intervention group were screened at multiple point…

This study tested whether a single low-dose pill containing three blood pressure medicines could prevent another stroke in people who had a brain bleed (intracerebral hemorrhage). Over 1,600 adults with a history of such a bleed and slightly high blood pressure took either the tr…

This study tested two ways of giving electroconvulsive therapy (ECT) to 156 people with severe depression. One method uses a frontoparietal placement and the other a temporoparietal placement. The goal was to see which works better for depression while causing fewer memory side e…

This study followed nearly 6,000 people with kidney disease from around the world. Researchers collected routine test results like kidney function and protein in urine over time. The goal was to better understand how kidney disease progresses, not to test a new treatment. Partici…